UCLA study reveals key signs for genetic testing in neurodevelopment disorders

In a new study, UCLA Health researchers have found that motor delay and low muscle tone were common signs of an underlying genetic diagnosis in children with neurodevelopment disorders.

Melatonin and Alzheimer’s; Napping-Parkinson’s Link; An Unusual ARIA Case

Could melatonin prevent — or treat — Alzheimer’s disease? A review in Molecular Psychiatry takes a close look. Exposure to individual metals and mixtures of

August 14, 2024

Results of aap Implantate AG’s Annual General Meeting underpin support for corporate strategy pursued – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): AGM/EGM Results of aap Implantate AG’s Annual General Meeting underpin support for corporate strategy pursued 27.07.2023 / 16:39

July 28, 2023

Subcutaneous Alzheimer’s Drug May Be on the Horizon

A subcutaneous version of the newly approved Alzheimer’s drug lecanemab (Leqembi) may be on the horizon. Weekly subcutaneous lecanemab 100 mg/mL injection appeared to be

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.